Canada Improves Hep C Treatment with Incivek Approval
Share
Follow Us
The Editors at Hepatitis Central
August 24, 2011
For people new to treatment and those who have failed a previous treatment attempt, Vertex’s Incivek can now be prescribed to Canadians with chronic Hepatitis C.
Vertex Pharma Says Health Canada Okays INCIVEK For People With Hepatitis C
8/22/2011
(RTTNews) – Vertex Pharmaceuticals Inc. (VRTX: News ) Monday said Health Canada has approved INCIVEK, or telaprevir, tablets for people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.
INCIVEK is approved for use in combination with pegylated-interferon and ribavirin, two other medicines approved to treat hepatitis C. It is indicated for people who are new to treatment, and for people who were treated previously but who did not achieve a sustained viral response.
Continue reading this entire article:
http://www.rttnews.com/Content/CanadianNews.aspx?Id=1697262&SM=1
